Equities

ICAD Inc

ICAD:NAQ

ICAD Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.59
  • Today's Change0.03 / 1.92%
  • Shares traded55.77k
  • 1 Year change-17.62%
  • Beta1.5064
Data delayed at least 15 minutes, as of Sep 20 2024 20:59 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

iCAD, Inc. provides artificial intelligence-powered cancer detection. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing the prevalent cancers earlier, a range of upgradeable computer-aided detection systems and workflow solutions for digital breast tomosynthesis, full-field digital mammography, magnetic resonance imaging and computed tomography. ProFound Suite offers 360-degree solutions for cancer detection, density assessment, and personalized risk evaluation, all based on a 2D or 3D mammogram’s collection of images. ProFound Density Assessment standardizes and simplifies breast density reporting, algorithmically examining a woman’s breast anatomy from the mammogram image.

  • Revenue in USD (TTM)18.80m
  • Net income in USD-4.54m
  • Incorporated1984
  • Employees67.00
  • Location
    ICAD Inc98 Spit Brook Rd Ste 100NASHUA 03062-5737United StatesUSA
  • Phone+1 (603) 882-5200
  • Fax+1 (603) 880-3843
  • Websitehttps://www.icadmed.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
SANUWAVE Health Inc24.90m-3.43m33.08m31.00------1.33-0.0095-0.00950.0218-0.03351.243.908.34803,064.50-17.07-136.54----71.5769.13-13.79-189.600.09990.1199----21.8461.61-150.72------
Vicarious Surgical Inc0.00-61.02m34.56m131.00--0.4795-----10.77-10.770.0012.220.00----0.00-61.68---66.62--------------0.00-------1,478.15------
United Health Products Inc0.00-1.84m34.73m6.00---------0.0075-0.00750.00-0.00810.000.00--0.00-662.95-6,446.86------53.19---132,561.200.0126-15.12-----100.00---55.45------
Accelerate Diagnostics Inc12.23m-37.91m34.81m134.00------2.85-2.07-2.070.6853-1.470.33632.145.2891,291.05-104.22-75.24-1,349.93-94.4627.1635.08-309.87-638.551.04--6.38---5.4316.291.40--0.7307--
Vaso Corp80.33m2.26m35.08m300.0012.961.3111.190.43670.01540.01540.45710.15241.1022.599.62267,766.703.107.605.0416.6261.2058.392.815.821.48--0.0028--2.181.84-57.46---22.33--
Movano Inc852.00k-26.83m35.62m30.00--2.12--41.81-0.4527-0.45270.01310.16960.0444--3.3828,400.00-139.74-151.50-176.37-188.58-87.21---3,149.06--5.23--0.0025------3.45--4.24--
BioNano Genomics Inc36.58m-204.10m36.12m344.00--0.37--0.9874-5.15-5.150.74961.140.18261.005.28106,334.30-101.86-56.82-123.67-67.8328.9725.38-557.98-505.761.11-61.510.0455--29.9024.65-75.34--38.51--
Precision Optics Corporation Inc19.41m-1.64m37.15m84.00--3.15--1.91-0.2706-0.27063.241.861.064.304.51231,098.50-8.98-6.71-13.18-10.5533.6533.65-8.43-5.021.05-8.860.1982--34.2339.1284.42--19.39--
Rapid Micro Biosystems Inc24.71m-50.46m37.29m193.00--0.3942--1.51-1.17-1.170.57112.200.17781.335.58128,036.30-36.30---40.86---14.22---204.22--4.62--0.003--31.44--13.71------
Apyx Medical Corp49.03m-28.37m37.76m252.00--2.56--0.7702-0.8188-0.81881.420.42570.76721.823.96194,567.50-44.55-25.24-58.21-29.9761.9066.11-58.08-46.004.45-7.790.693--17.6125.8219.28--7.99--
T2 Biosystems Inc7.16m-48.26m38.46m113.00------5.37-10.70-10.701.09-0.33910.24352.825.4163,398.23-164.01-106.01---253.03-86.96-12.60-673.67-317.930.359-12.442.00---67.75-7.2919.66---20.19--
electroCore, Inc.21.28m-14.23m38.69m68.00--3.37--1.82-2.19-2.193.251.781.161.4154.85312,955.90-77.78-70.73-125.05-88.9683.6175.81-66.84-352.822.12--0.00--86.5774.4215.02---5.88--
Co-Diagnostics Inc9.14m-37.57m40.53m155.00--0.5598--4.44-1.27-1.270.30772.270.09441.1911.0858,948.20-38.835.77-41.046.1559.8382.24-411.1910.948.81--0.000.00-80.09179.54-148.15--101.27--
iCAD Inc18.80m-4.54m41.40m67.00--1.33--2.20-0.1735-0.0880.71851.170.44881.063.14280,537.30-10.84-23.94-13.90-34.1486.0476.96-24.16-45.024.13--0.00---12.54-7.5329.32--23.88--
Lucid Diagnostics Inc3.80m-54.15m44.20m70.00------11.63-1.23-1.230.08570.32380.0992--38.9754,285.71-121.82---274.96---67.39---1,227.76--1.71--0.4178--544.03--6.24------
LENSAR Inc45.12m-12.56m50.03m130.00--2.10--1.11-1.11-1.113.923.240.68061.259.08347,107.70-18.94-30.97-22.49-36.9449.8751.04-27.83-52.302.15--0.00--19.2511.5727.77---42.91--
Data as of Sep 20 2024. Currency figures normalised to ICAD Inc's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.